Growth Factors · 1996 · 12 citations · 34 references
MedicineCell BiologyOncologyCarcinogenesisMolecular OncologyOncogenesCalcium SignalingCancer Cell SignalingMast Cell ActivationCytokine Signaling In CancerCytokine Signaling In TumorsHybridoma Cell LinesMast Cell BiologyMast Cell Calcium SignalingMast Cell Signal TransductionMast Cell Stabilization MechanismsMrna Degradation Pathways
Autocrine interleukin-3 (IL-3) expression of v-H-ras transformed mast cell tumors involves either IL-3 mRNA stabilization (class-I tumors) or enhanced IL-3 transcription (class-II tumors). Since calcium ionophores induce IL-3 expression in untransformed PB-3c cells by transcript stabilization, we asked whether class-I tumor could still respond to calcium ionophores. We found that ionomycin treatment further increased IL-3 mRNA expression of class-I tumor cells. Following ionomycin wash-out, IL-3 mRNA decay was slower in class-I tumor cells than in class-II tumor or precursor cell lines (t1/2 > 50 min versus < 20 min, respectively). Somatic cell fusion of the class-I tumor cells with the non-tumorigenic PB-3c cells resulted in reversion to rapid decay after ionomycin wash-out. The data indicate that a recessive defect of IL-3 mRNA degradation can be revealed in class-I tumor cells by transient calcium ionophore stimulation. However, IL-3 mRNA stabilization operating constitutively in class-I tumor cells appears to be distinct from the ionomycin induced process.
34
Daniel Caput, Bruce Beutler, K. Hartog et al. · Proceedings of the National Academy of Sciences · 1986 · 1.5K citations · Full text